iBio, Inc Common Stock

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$200
$0
$200
$0
Gross Profit
200
EBITDA
-4,525
-4,026
-3,654
EBIT
-4,807
-4,307
-3,932
Net Income
-5,163
-4,861
-4,364
-3,989
Net Change In Cash
200
0
200
0
Free Cash Flow
-4,616
-3,119
-3,870
-3,715
Cash
8,582
4,959
7,015
11,038
Basic Shares
19,349
9,862
9,132
8,633

Annual Financials

Values in thousands 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Revenue
$400
$225
$50
$1,884
Gross Profit
225
50
2,167
EBITDA
-18,377
-14,021
-28,107
-25,722
EBIT
-15,271
-29,311
-29,513
Net Income
-18,377
-24,907
-29,311
-51,005
Net Change In Cash
400
225
50
1,884
Free Cash Flow
-15,320
-18,764
-36,174
-49,110
Cash
8,582
14,210
4,301
22,676
Basic Shares
10,499
3,831
1,225
872

Earnings Calls

Quarter EPS
2025-06-30
-$0.32
2025-03-31
-$0.49
2024-12-31
-$0.48
2024-09-30
-$0.46